Elevated SPAP was identified as another significant predictor in our study, which corroborated findings by Tang et al., who linked pulmonary hypertension to poor outcomes in TAVI populations [23]. The gene discussed is PDZK1IP1; the disease is pulmonary arterial hypertension.